Upgrade to SI Premium - Free Trial

LifeMD, Inc. (LFMD)

4.94 +0.07 (1.44%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/6/26)

Latest Headlines

Form 4 LifeMD, Inc. For: Jun 01 Filed by: Sripad Umesh June 3, 2026 8:54 PM - SEC Filing Form 3 LifeMD, Inc. For: Jun 01 Filed by: Sripad Umesh June 3, 2026 8:51 PM - SEC Filing LifeMD names Umesh Sripad as chief technology officer June 1, 2026 8:05 AM - StreetInsider LifeMD Appoints Umesh Sripad as Chief Technology Officer June 1, 2026 8:05 AM - Globe NewsWire H.C. Wainwright Reiterates Buy Rating on LifeMD Inc (LFMD) May 27, 2026 6:49 AM - StreetInsider LifeMD to Participate in Upcoming Investor Conferences May 15, 2026 8:00 AM - Globe NewsWire Form 4 LifeMD, Inc. For: May 11 Filed by: Kavthekar Atul May 13, 2026 5:12 PM - SEC Filing Form 10-Q LifeMD, Inc. For: Mar 31 May 6, 2026 5:25 PM - SEC Filing Form 8-K LifeMD, Inc. For: May 06 May 6, 2026 5:06 PM - SEC Filing LifeMD, Inc. (LFMD) Tops Q1 EPS by 1c May 6, 2026 4:16 PM - StreetInsider LifeMD Reports First Quarter 2026 Results May 6, 2026 4:06 PM - Globe NewsWire BTIG highlights key trends from Boston Digital Health Summit May 5, 2026 5:19 AM - StreetInsider Form ARS LifeMD, Inc. For: Dec 31 April 30, 2026 4:26 PM - SEC Filing Form DEFA14A LifeMD, Inc. April 30, 2026 4:22 PM - SEC Filing Form DEFA14A LifeMD, Inc. April 30, 2026 4:18 PM - SEC Filing Form DEF 14A LifeMD, Inc. For: Apr 30 April 30, 2026 4:09 PM - SEC Filing LifeMD to Report First Quarter 2026 Financial Results on May 6 April 27, 2026 8:00 AM - Globe NewsWire LifeMD adds Eli Lilly's oral weight loss drug Foundayo to platform April 10, 2026 8:16 AM - StreetInsider LifeMD® Now Offering Eli Lilly and Company’s Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management April 10, 2026 8:15 AM - Globe NewsWire Form 4 LifeMD, Inc. For: Mar 30 Filed by: Pisano Christopher A April 1, 2026 5:34 PM - SEC Filing Form 3 LifeMD, Inc. For: Mar 16 Filed by: Pisano Christopher A April 1, 2026 5:32 PM - SEC Filing Form 3 LifeMD, Inc. For: Mar 16 Filed by: Kavthekar Atul April 1, 2026 5:32 PM - SEC Filing Form S-8 LifeMD, Inc. April 1, 2026 4:58 PM - SEC Filing LifeMD launches Novo Nordisk Wegovy subscription program March 31, 2026 8:46 AM - StreetInsider LifeMD Offers Novo Nordisk's Industry-First Wegovy® Telehealth Subscription Program March 31, 2026 8:45 AM - Globe NewsWire LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock March 24, 2026 4:05 PM - Globe NewsWire Form 144 LifeMD, Inc. Filed by: FRIEDEMAN JESSICA March 23, 2026 10:47 AM - SEC Filing Form 8-K LifeMD, Inc. For: Mar 16 March 18, 2026 4:17 PM - SEC Filing LifeMD names Atul Kavthekar as chief financial officer March 16, 2026 8:01 AM - StreetInsider LifeMD Appoints Veteran Healthcare Finance Executive as Chief Financial Officer and Expands Leadership Team March 16, 2026 8:00 AM - Globe NewsWire Mizuho Upgrades LifeMD Inc (LFMD) to Outperform March 16, 2026 4:15 AM - StreetInsider LifeMD Inc (LFMD) PT Raised to $10 at Freedom Capital Markets March 12, 2026 10:07 AM - StreetInsider LifeMD Inc (LFMD) PT Raised to $10 at H.C. Wainwright March 11, 2026 6:56 AM - StreetInsider Form 10-K LifeMD, Inc. For: Dec 31 March 10, 2026 4:57 PM - SEC Filing Cantor Fitzgerald Reiterates Overweight Rating on LifeMD Inc (LFMD) on Momentum Across Offering March 10, 2026 9:21 AM - StreetInsider Form 8-K LifeMD, Inc. For: Mar 09 March 9, 2026 4:38 PM - SEC Filing LifeMD, Inc. (LFMD) Tops Q4 EPS by 3c, provides guidance March 9, 2026 4:09 PM - StreetInsider LifeMD Reports Fourth Quarter and Full Year 2025 Results March 9, 2026 4:05 PM - Globe NewsWire Full Article List